Navigation Links
HRT: Boon or Bane?

Hormone Replacement Therapy (HRT) was once “the” treatment for all ailments of menopause. But with increasing reports on the negative effects of HRT, should it be taken? //

HRT can help women at menopausal stage to cope with various problems like hot flashes etc. But there are several side effects to think about. According to recent reports, HRT is connected with a 110 % increase in breast cancer risk among smokers, a 41 % rise in stroke risk and a 22 % increase in cardiovascular problems.

But some doctors say these findings -- from a halted long-term study-- don't apply to most. Only older women were tested -- with a HRT regimen not recommended today.

"Unfortunately, many women who are good candidates for hormone therapy are just terrified of hormone therapy," Women's Health Specialist Holly Thacker, M.D., of The Cleveland Clinic Foundation, tells Ivanhoe.

Yet Dr. Thacker says women don't have to be afraid. New studies show short-term, low-dose hormone therapy can relieve symptoms like hot flashes. And as long as you don't take it for more than 10 years, it does not appear to increase breast cancer risk.

"Not all women need hormones. Some women have too many hormones. Some women have just the right amount. And then there's some that don't have enough," Dr. Thacker says. "That really has to be sorted out."
Once it is sorted out, many women, like Nancy Tyrell, can feel like their old selves for many more years. With HRT -- she's been able to claim back her love life. She says, "It's the best that it's ever been!"
Women with a history of breast cancer or blood clots should avoid hormone therapy. Alternatives to HRT include soy, herbals like black cohosh and localized hormone rings. Many doctors now recommend starting HRT during menopause and slowly tapering off to no treatment. Source: Eurekalert
'"/>




Page: 1

Related medicine news :

1. Ultrasound Technology - Boon or a Bane?
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... ... December 08, 2016 , ... California Senate Bill (SB) ... per workers’ compensation claim in 2013 and 2014, according to CompScope™ Medical Benchmarks ... (WCRI) . , According to the study, medical payments per claim in California decreased ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... financial planning services from offices headquartered in Little Rock, has initiated a charity ... According to the National Foundation to End Senior Hunger, Arkansas ranks first in ...
(Date:12/8/2016)... FL (PRWEB) , ... December 08, 2016 , ... Coppin ... business owners and families in and around the Cape Coral area, is embarking on ... Chapin Food Bank of Southwest Florida. , The Harry Chapin Food Bank of Southwest ...
(Date:12/7/2016)... ... December 07, 2016 , ... DrugDev again demonstrated its dedication to ... of the early adopters completing EU-U.S. Privacy Shield Certification from the U.S. Department of ... both sides of the Atlantic with a mechanism to comply with EU data protection ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... the drug in their bodies, a researcher at the Icahn School of Medicine ... Research. , The study found that when young children are exposed to secondhand ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Dec. 8, 2016  Agenovir Corporation, a company ... antiviral therapeutics, today announced that it appointed ... and a member of the board of directors. ... with a deep background in both founding and ... of Agenovir, co-president of Chan Zuckerberg  Biohub ...
(Date:12/8/2016)... NORWALK, Conn. , Dec. 8, 2016   Mederi Therapeutics Inc . has ... for Stretta Therapy, a non-surgical treatment for chronic gastroesophageal reflux disease (GERD). ... ... procedure performed and broadcast during the Chinese Congress of Digestive Endoscopy, by Professor Jun ... , , "We ...
(Date:12/8/2016)... ANTONIO , Dec. 8, 2016 Eli ... announced that the neoMONARCH study of abemaciclib, a cyclin-dependent ... primary endpoint of reducing expression of Ki67, a biomarker ... data from the Phase 2 trial presented during the ... Cancer Symposium (SABCS) evaluated abemaciclib, both alone or in ...
Breaking Medicine Technology: